A coxib a day won't keep the doctor away (Q45027701)

8 December 2017

A coxib a day won't keep the doctor away (English)

1 reference

8 December 2017

1

1 reference

8 December 2017

2

1 reference

PubMed ID

15325809

8 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

364

1 reference

8 December 2017

9435

1 reference

8 December 2017

639-640

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Nonsteroidal anti-Inflammatory drugs and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

COX-2 and beyond: Approaches to prostaglandin inhibition in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Cyclooxygenase-2 expression and inhibition in atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Selective COX-2 inhibition improves endothelial function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916906-7

7 January 2021

10.1016/S0140-6736(04)16906-7

Identifiers

DOI

1 reference

8 December 2017

1 reference

PubMed ID

15325809